<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03866291</url>
  </required_header>
  <id_info>
    <org_study_id>2017-0123</org_study_id>
    <nct_id>NCT03866291</nct_id>
  </id_info>
  <brief_title>ESBL in Patients Returning to Sweden With Traveller's Diarrhoea</brief_title>
  <official_title>ESBL-producing Enterobacteriaceae in Patients With Traveller's Diarrhoea- a Prospective Cohort Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lund University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lund University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with traveller's diarrhoea frequently harbour Extended Spectrum Betalactamase
      (ESBL)-producing Enterobacteriaceae (EPE) returning from EPE-endemic areas.

      This study investigates to what extent travellers returning to Sweden with traveller's
      diarrhoea carry ESBL in their stool. The isolates are examined further according to species,
      phenotype, antibiogram and whole genome sequencing.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Samples sent to the department of clinical microbiology in Lund, Sweden for culture of
      salmonella, shigella, yersinia or campylobacter are also cultured selectively for ESBL.

      All patients are contacted by mail with the results. ESBL-positive patients are invited to
      submit further faecal cultures and blood samples during one year follow up time, to
      investigate how long the patient is colonized with ESBL.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Actual">June 20, 2019</completion_date>
  <primary_completion_date type="Actual">June 20, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion ESBL-colonized after one year.</measure>
    <time_frame>1 year</time_frame>
    <description>Defined as a Positive ESBL-culture obtained 12 months after travel</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">305</enrollment>
  <condition>Antibiotic Resistant Infection</condition>
  <condition>Antibiotic Resistant Strain</condition>
  <condition>Traveler's Diarrhea</condition>
  <arm_group>
    <arm_group_label>ESBL carrier</arm_group_label>
    <description>This cohort is followed for a year with additional selective ESBL cultures after 1, 3, 6 and 12 months. In the end of the year a questionnaire is handed in to the study group.
Sera is donated after 4-6 weeks and in year.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non ESBL-carrier</arm_group_label>
    <description>No further rectal cultures. In the end of the year a questionnaire is handed in to the study group. Sera is donated after 4-6 weeks and in year.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention, observational</intervention_name>
    <description>See above</description>
    <arm_group_label>ESBL carrier</arm_group_label>
    <arm_group_label>Non ESBL-carrier</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Rectal cultures and blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Travellers of all ages
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Travellers diarrhoea

          -  foreign traveller

        Exclusion Criteria:

          -  foreign traveller but no symptoms
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Oskar Ljungquist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lunds Universitet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oskar Ljungquist</name>
      <address>
        <city>Helsingborg</city>
        <state>Sk√•ne</state>
        <zip>25187</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>February 27, 2019</study_first_submitted>
  <study_first_submitted_qc>March 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2019</study_first_posted>
  <last_update_submitted>July 1, 2019</last_update_submitted>
  <last_update_submitted_qc>July 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dysentery</mesh_term>
    <mesh_term>Diarrhea</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

